Is Novo Nordisk Stock a Buy Now?
Weight-loss drugs are the health craze of 2023. According to the management of , America's largest retailer, drugs like Ozempic and Wegovy have begun impacting food sales.
Perhaps it shouldn't be surprising that shares of Novo Nordisk (NYSE: NVO), the pharmaceutical company behind Ozempic and Wegovy, have done well. The stock is up 36% since January and more than 70% over the past twelve months.
So, is it too late to enjoy this potentially monumental shift in the healthcare landscape? Or is Novo Nordisk's fortune a fad, like many previous health trends? Here's what you need to know.
Source Fool.com
Walmart Inc. Stock
€59.92
-0.430%
The stock is one of the favorites of our community with 69 Buy predictions and 1 Sell predictions.
With a target price of 156 € there is potential for a 160.35% increase which would mean more than doubling the current price of 59.92 € for Walmart Inc..
